In addition, RGS16 can inhibit the epidermal growth factor (EGF)-mediated proliferation of breast cancer cells [38]; and it is also associated with lymph node metastasis of pancreatic cancer and may be a prognostic marker for pancreatic cancer [39]. Here, RGS16 is linked to metastatic malignant neoplasm in the lymph nodes.